Change in taste loss of taste.
Glp 1 side effects.
Incretin mimetics are a relatively new group of injectable drugs for treatment of type 2 diabetes.
Inflammation of the pancreas pancreatitis which may be severe is another side effect.
Glp 1 ras commonly cause digestive side effects such as.
Low blood sugar levels hypoglycemia are a more serious risk linked to the glp 1 class of medications.
Bleeding blistering burning coldness discoloration of the skin feeling of pressure hives infection inflammation itching lumps numbness pain rash redness scarring soreness stinging swelling tenderness tingling ulceration or warmth at the injection site other side effects not listed may also occur in some patients.
Pain at the site of injection.
Side effects of incretin mimetics include.
The most frequently reported treatment emergent adverse events aes were decreased appetite and gastrointestinal aes constipation diarrhea abdominal discomfort abdominal distension vomiting and nausea.
The most common side effects of liraglutide include nausea diarrhea and headache.
The most common symptoms associated with the use of glp 1 receptor agonists are gastrointestinal symptoms mainly nausea.
Other common adverse effects include injection site reactions headache and nasopharyngitis but these effects do not usually result in discontinuation of the drug.
Feelings of early fullness lower appetite nausea vomiting diarrhea.
These aes were generally dose dependent and mild in severity.